biologics

Welcome to the 'biologics' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'biologics'.

Latest blogosphere posts tagged “biologics”

• Biotech Provisions in Senate Health Care Bill Promotes Innovation

  
  IPWatchdog.com | Patents & Patent Law — Authority: 131
  WASHINGTON, DC (December 24, 2009) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on today’s vote by the Senate to pass The Patient Protection and Affordable Care Act of 2009:The health care reform bill passed today by the Senate includes many ...
  2 days ago

• Merck Acquires Contract Manufacturer Avecia as it Positions Itself to Enter the Follow on Biologics Market

  
  Bio Job Blog — Authority: 125
  Merck & Co. Inc., and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of UK-based Avecia; a contract manufacturing organization with specific expertise in microbial-derived biologics. A Merck executive commented on ...
  1 week ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 545
  Hello, everyone. Nice to see you again. We are feeling bright and shiny today, although we are about to begin the usual process of hustling short people off to the schoolhouse. So while we grapple, here are a few items to help you endure your own routine. Hope today is a good one for you…. Roche, Ipsen Diabetes ...
  1 week ago

• UCSF Physicians Respond to Rep. Eshoo on Evergreening Loophole in Biologics Bill

  
  Firedoglake — Authority: 729
  photo: greenasian via Flickr By: Alexander C. Tsai, M.D., Ph.D. and Nicholas Rosenlicht, M.D. As psychiatrists who provide critical psychological counseling and support for many patients living with HIV/AIDS in San Francisco, we have observed firsthand how “evergreening” by the pharmaceutical industry has ...
  1 week ago

• Pfizer dives into generic biologics

  
  Bizmology — Authority: 122
  Not too big of a surprise that Pfizer wants to stick its nose  into the generic biotech (or follow-on biologics) market — it’s a steadily rising trend in the pharmaceutical industry these days. While the wave of companies adding traditional generic drugs to their repertoire has been growing  for some time, ...
  2 weeks ago

• Ready to rumble: Pfizers generic biotech drug push could pit it against Amgen

  
  DailyFinance — Authority: 766
  Filed under: Company News , Healthcare For years, Pfizer ( PFE ) has been trying to prepare for the "patent cliff" its heading for in 2011. Thats when its cholesterol drug Lipitor -- the biggest-selling drug ever with $12 billion in annual sales -- will fall off the rolls of protected drugs. Mindful of that date, ...
  2 weeks ago

• Having Plans

  
  The Seated View — Authority: 120
  A couple of weeks ago, I watched a documentary called 65_RedRoses about a young woman with cystic fibrosis who was waiting for a double lung transplant. Its a nailbiter and you need Kleenex and in the end, when you see her on the Dragon boat team of people whove had transplants, paddling furiously, you are as happy ...
  2 weeks ago

• Fact vs. Fiction: The Truth on Biologics and Biosimilars

  
  IPWatchdog.com | Patents & Patent Law — Authority: 131
  For many months we have been hearing about the government attempts to “reform” health care in the United States, and this weekend the United States Senate is actually working, yes Senators working on a weekend, as the contentious debate continues. Even a relatively rare Presidential visit to Capitol Hill is ...
  2 weeks ago

• Up And Down The Ladder… Job Changes

  
  Pharmalot — Authority: 545
  Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants to know who is coming and going, especially with all the ...
  3 weeks ago

• Two Physicians Want Congress to Close "Evergreening" Loophole in FOB Legislation

  
  Patent Docs — Authority: 430
  By Donald Zuhn -- In an Op-Ed appearing in Tuesdays San Jose Mercury News, two physicians have asked Rep. Anna Eshoo (D-CA) to close what they believe is a loophole in follow-on biologics (FOB) legislation currently before Congress ("Eshoo needs to close loophole in biologics legislation"). The authors of the piece, ...
  3 weeks ago

• Follow-on Biologics News Briefs - No. 10

  
  Patent Docs — Authority: 430
  By Donald Zuhn -- Affordable Health Care for America Act Placed on Senate Legislative Calendar The Affordable Health Care for America Act (H.R. 3962), which was passed by the House of Representatives on November 7th by a narrow five-vote margin (220-215), has now been placed on the Senate Legislative Calendar. The ...
  3 weeks ago

Comments about biologics